SOURCE: Horizon Pharma

Horizon Pharma

June 17, 2014 07:30 ET

Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014

DEERFIELD, IL--(Marketwired - Jun 17, 2014) - Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd N. Smith, executive vice president, chief commercial officer, will present in a fireside chat format discussion at the JMP Securities Healthcare Conference 2014 on Tuesday, June 24, 2014 at 11:30 a.m. Eastern Time in New York, NY. Mr. Smith will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.

About Horizon Pharma

Horizon Pharma, Inc. is a commercial stage, specialty pharmaceutical company that markets DUEXIS®, VIMOVO® and RAYOS®/LODOTRA®, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines or companies where it can execute a targeted commercial approach among specific target physicians such as primary care physicians, orthopedic surgeons and rheumatologists, while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.

Contact Information

  • Contacts
    Robert F. Carey
    Executive Vice President, Chief Business Officer
    Email Contact